Shkreli Says Retrophin Has Waived Privilege For Katten Docs
Attorneys for former Turing Pharmaceuticals Inc. CEO Martin Shkreli on Wednesday said that former Shkreli-helmed drugmaker Retrophin Inc. has waived its attorney-client privilege with respect to communications with his former lawyers at...To view the full article, register now.
Already a subscriber? Click here to view full article